Cargando…

Gender-specific association between the regular use of statins and the risk of irritable bowel syndrome: A population-based prospective cohort study

Introduction: In addition to lipid-lowering effects, statins might modulate the gut microbiome and alleviate systematic inflammation, which in turn, may have a protective effect against irritable bowel syndrome (IBS). The aim of our study was to evaluate the gender-specific association between stati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiaoying, Liu, Yuyao, Ou, Yanghui, Yang, Man, Yuan, Jinqiu, He, Qiangsheng, Li, Yanfei, Mi, Ningning, Xie, Peng, Li, Wenjing, Wu, Siqin, Qin, Xiwen, Qi, Jian, Xia, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853052/ https://www.ncbi.nlm.nih.gov/pubmed/36686671 http://dx.doi.org/10.3389/fphar.2022.1044542

Ejemplares similares

Association Between Regular Use of Gastric Acid Suppressants and Subsequent Risk of Cholelithiasis: A Prospective Cohort Study of 0.47 Million Participants
por: Yang, Man, et al.
Publicado: (2022)

Effects of Chang-Kang-Fang Formula on the Microbiota-Gut-Brain Axis in Rats With Irritable Bowel Syndrome
por: Ling, Xiwen, et al.
Publicado: (2022)

Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
por: Colomier, Esther, et al.
Publicado: (2021)

An Overview of Systematic Reviews of Herbal Medicine for Irritable Bowel Syndrome
por: Jun, Hyejin, et al.
Publicado: (2022)

Efficacy and Safety of Probiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
por: Li, Bing, et al.
Publicado: (2020)

An Integrated Gut Microbiota and Network Pharmacology Study on Fuzi-Lizhong Pill for Treating Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhen, Zhang, et al.
Publicado: (2021)

Drug Development for the Irritable Bowel Syndrome: Current Challenges and Future Perspectives
por: De Ponti, Fabrizio
Publicado: (2013)

Novel insights which may translate into treatments for irritable bowel syndrome
por: Izzo, Angelo A.
Publicado: (2013)

Epidemiology, Clinical Features, and Prescribing Patterns of Irritable Bowel Syndrome in Taiwan
por: Lai, Yu-Tung, et al.
Publicado: (2021)

Alleviating insomnia should decrease the risk of irritable bowel syndrome: Evidence from Mendelian randomization
por: Bao, Wenzhao, et al.
Publicado: (2022)

Study on the pathogenesis of MiR-6324 regulating diarrheal irritable bowel syndrome and bioinformatics analysis
por: Xiao, Jin, et al.
Publicado: (2023)

Relationships between beliefs about statins and non-adherence in inpatients from Northwestern China: a cross-sectional survey
por: Li, Haiyan, et al.
Publicado: (2023)

Genetic factors, adherence to healthy lifestyle behaviors, and risk of bladder cancer
por: He, Qiangsheng, et al.
Publicado: (2023)

Efficacy and safety of fecal microbiota transplantation for the treatment of irritable bowel syndrome: an overview of overlapping systematic reviews
por: Zhang, Di, et al.
Publicado: (2023)

Global research progress of visceral hypersensitivity and irritable bowel syndrome: bibliometrics and visualized analysis
por: Tian, Siyu, et al.
Publicado: (2023)

Sex-Gender Differences in Irritable Bowel Syndrome
por: Kim, Young Sun, et al.
Publicado: (2018)

Ameliorative effect and mechanism of Si-Ni-San on chronic stress-induced diarrhea-irritable bowel syndrome in rats
por: Chen, Hui-Yu, et al.
Publicado: (2022)

Synergistic Effect of Berberine-Based Chinese Medicine Assembled Nanostructures on Diarrhea-Predominant Irritable Bowel Syndrome In Vivo
por: Li, Lei, et al.
Publicado: (2020)

Suppression of PTRF Alleviates Post-Infectious Irritable Bowel Syndrome via Downregulation of the TLR4 Pathway in Rats
por: Zhou, Hui-hui, et al.
Publicado: (2021)

Global trends in research on irritable bowel syndrome and the brain–gut axis: Bibliometrics and visualization analysis
por: Wu, Peng-Ning, et al.
Publicado: (2022)

Chinese Herbal Medicine for Irritable Bowel Syndrome: A Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials
por: Zheng, Hui, et al.
Publicado: (2021)

trans-Resveratrol Ameliorates Stress-Induced Irritable Bowel Syndrome-Like Behaviors by Regulation of Brain-Gut Axis
por: Xu, Ying, et al.
Publicado: (2018)

Eluxadoline Versus Antispasmodics in the Treatment of Irritable Bowel Syndrome: An Adjusted Indirect Treatment Comparison Meta-analysis
por: Qin, Di, et al.
Publicado: (2022)

Low FODMAP Diet and Probiotics in Irritable Bowel Syndrome: A Systematic Review With Network Meta-analysis
por: Xie, Chao-Rong, et al.
Publicado: (2022)

Utilization patterns and prescription characteristics of traditional Chinese medicine among patients with irritable bowel syndrome in Taiwan
por: Gu, Ye, et al.
Publicado: (2023)

Is There True Gender Difference of Irritable Bowel Syndrome in Asia?
por: Jung, Hye-Kyung
Publicado: (2011)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Tong-Xie-Yao-Fang Regulates 5-HT Level in Diarrhea Predominant Irritable Bowel Syndrome Through Gut Microbiota Modulation
por: Li, Junchen, et al.
Publicado: (2018)

Factors related to irritable bowel syndrome and differences among subtypes: A cross-sectional study in the UK Biobank
por: Wang, Kexin, et al.
Publicado: (2022)

Patchouli alcohol improved diarrhea-predominant irritable bowel syndrome by regulating excitatory neurotransmission in the myenteric plexus of rats
por: Chen, Wanyu, et al.
Publicado: (2022)

Preparation, Evaluation and Bioavailability Studies of Eudragit Coated PLGA Nanoparticles for Sustained Release of Eluxadoline for the Treatment of Irritable Bowel Syndrome
por: Anwer, Md. K., et al.
Publicado: (2017)

Pharmacokinetic Differences of Wuji Pill Components in Normal and Chronic Visceral Hypersensitivity Irritable Bowel Syndrome Rats Attributable to Changes in Tight Junction and Transporters
por: Gong, Zipeng, et al.
Publicado: (2022)

Arterial stiffness evaluation in patients with irritable bowel syndrome: Role of antihypertensive drugs and statins
por: Varol, Ercan
Publicado: (2015)

Comparative efficacy and safety of probiotics for the treatment of irritable bowel syndrome: a systematic review and network meta-analysis protocol
por: Yang, Man, et al.
Publicado: (2019)

Systematic review and meta-analysis of Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: Evidence for clinical practice and future trials
por: Liang, Shi-Bing, et al.
Publicado: (2022)

Gender and Weight Influence Quality of Life in Irritable Bowel Syndrome
por: Sherwin, LeeAnne B., et al.
Publicado: (2017)

A Distinct Profile of Tryptophan Metabolism along the Kynurenine Pathway Downstream of Toll-Like Receptor Activation in Irritable Bowel Syndrome
por: Clarke, Gerard, et al.
Publicado: (2012)

Intestinal anti-inflammatory and visceral analgesic effects of a Serpylli herba extract in an experimental model of irritable bowel syndrome in rats
por: Ruiz-Malagón, Antonio Jesús, et al.
Publicado: (2022)

No Associations Between Regular Use of Proton Pump Inhibitors and Risk of All-Cause and Cause-Specific Mortality: A Population-Based Cohort of 0.44 Million Participants
por: He, Qiangsheng, et al.
Publicado: (2021)

Alpha 2 Delta (α(2)δ) Ligands, Gabapentin and Pregabalin: What is the Evidence for Potential Use of These Ligands in Irritable Bowel Syndrome
por: Gale, Jeremy D., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qpvmscb26ndrsj64p0r9iu8dq7